Skip to main content

Table 1 Clinicopathological characteristics of patients with epithelial ovarian cancer and their correlations with SLP-2 expression

From: Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival

Characteristics

Number of cases (%)

SLP-2 expression (%)

P value

Low or no expression

High expression

 

Age (years)

   

0.433

<45

49 (35)

11 (22.4)

38 (77.6)

 

≥45

91 (65)

26 (29.7)

65 (70.3)

 

CA125 level (before surgery)

   

0.067

<500U/ml

67 (47.9)

23 (34.3)

44 (65.7)

 

≥500U/ml

73 (52.1)

15 (20.5)

58 (79.5)

 

Tumour size

   

0.501

<10 cm

58 (41.4)

14 (24.1)

44 (75.8)

 

≥10 cm

82 (58.6)

24 (29.3)

58 (70.7)

 

The volume of ascites

   

0.014

<1000 ml

100 (71.4)

33 (33.0)

67 (67.0)

 

≥1000 ml

40 (28.6)

5 (12.5)

35 (87.5)

 

Peritoneal cytology

   

0.001

Positive

68 (48.6)

10 (14.7)

58 (85.3)

 

Negative

72 (51.4)

28 (38.9)

44 (61.1)

 

Pathological type

   

0.064

Serous

80 (57.1)

20 (25.0)

60 (75.0)

 

Mucinous

14 (10.0)

8 (57.1)

6 (42.9)

 

Poorly differentiated

36 (25.7)

8 (22.2)

28 (77.8)

 

Othersa

10 (7.1)

2 (20.0)

8 (80.0)

 

Grade of differentiation

   

0.072

G1

59 (42.1)

11 (18.6)

48 (81.4)

 

G2

46 (32.9)

13 (28.3)

33 (71.7)

 

G3

18 (12.9)

9 (50.0)

9 (50.0)

 

Unknown

17 (12.1)

5 (29.4)

12 (70.6)

 

FIGO stage

   

0.001

I

30 (21.4)

17 (56.7)

13 (43.3)

 

II+ III + IV

110 (78.6)

21 (19.1)

89 (88.9)

 

Lymph node metastasis

   

0.688

Positive

21 (15.0)

7 (33.3)

14 (66.7)

 

Negative

23 (16.4)

5 (21.7)

18 (78.3)

 

Not do RPLNDb

96 (68.6)

26 (27.1)

70 (72.9)

 

Cytoreductive surgeryc

   

0.185

Optimal

107 (76.4)

32 (29.9)

75 (70.1)

 

Suboptimal

33 (23.6)

6 (18.2)

27 (81.8)

 
  1. aEndometrioid adenocarcinoma, two cases; clear cell carcinoma, three cases; mixed epithelial carcinoma, five cases
  2. bRPLND, retroperitoneal lymph node dissection, including unilateral or bilateral pelvic lymphadenectomy and /or paraortic lymphadenectomy
  3. cCytoreductive surgery: Optimal, the diameter of the largest residual lesions was < 2 cm;Suboptimal, the diameter of the largest residual lesions was ≥ 2 cm